Accessibility Menu
 
Arrow-Thin-Down
S&P 500
7,195.35
-0.5%
-34.77
Arrow-Thin-Down
DJI
48,952.67
-1.1%
-546.60
Arrow-Thin-Down
NASDAQ
25,046.02
-0.3%
-68.42
Arrow-Thin-Down
Bitcoin
$80,211.00
+2.0%
+$1,536.41
Arrow-Thin-Down
AAPL
$276.72
-1.2%
-$3.42
Arrow-Thin-Down
AMZN
$270.61
+0.9%
+$2.35
Arrow-Thin-Down
GOOG
$380.25
-0.8%
-$2.97
Arrow-Thin-Down
META
$611.48
+0.4%
+$2.74
Arrow-Thin-Down
MSFT
$413.86
-0.1%
-$0.58
Arrow-Thin-Down
NVDA
$197.77
-0.3%
-$0.68
Arrow-Thin-Down
TSLA
$391.95
+0.3%
+$1.13
Most Active StocksDaily Stock GainersDaily Stock Losers

Definium Therapeutics

(NASDAQ) DFTX

Current Price$21.89
Market Cap$2.37B
Since IPO (2020)+149%
5 Year-63%
1 Year+229%
1 Month+5%

Definium Therapeutics Financials at a Glance

Market Cap

$2.37B

Revenue (TTM)

$0.00

Net Income (TTM)

$183.79M

EPS (TTM)

$-2.07

P/E Ratio

-10.49

Dividend

$0.00

Beta (Volatility)

1.55 (High)

Price

$21.89

Volume

667,258.867

Open

$21.60

Previous Close

$21.70

Daily Range

$21.29 - $22.04

52-Week Range

$6.03 - $26.25

DFTX News

Hands holding some pills from a bottle

Best Psychedelic Stocks to Buy in 2026 and How to Invest

Keith SpeightsApr 10, 2026
BuyAlert-Red.png

This $6 Million Bet Adds a Brain Health Biotech to Portfolio Dominated by Clinical Stage Names

Jonathan PoncianoMar 18, 2026
GettyImages-1482773020

If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today

Keith NoonanAug 12, 2025
featured-earnings-leadership-highlights.png

MindMed Reports Strong Q2 2025 Results

Motley Fool Markets TeamAug 11, 2025
Healthcare professional inspecting charts

1 Reason to Buy MindMed (MNMD)

Eric VolkmanAug 7, 2025
Foolcom-Featured.png

MindMed (MNMD) Q2 Net Loss Jumps 625%

Motley Fool Markets TeamAug 1, 2025
Two people in white lab coats looking at a computer display

Why Mind Medicine Gave Investors a Powerful Buzz in May

Eric VolkmanJun 4, 2025
Person in a lab gazing into a microscope

Why Mind Medicine Stock Vaulted More Than 8% Higher Today

Eric VolkmanMay 20, 2025
Page 1

DFTX: Motley Fool Moneyball Superscore

62

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Definium Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

106

CEO

Robert Barrow, CFA

Website

www.mindmed.co

Headquarters

New York, NY 10007, US

DFTX Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-64%

Return on Capital

-45%

Return on Assets

-42%

Earnings Yield

-9.53%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.37B

Shares Outstanding

109.07M

Volume

667.26K

Avg. Volume

1.75M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$166.31M

EBITDA

$178.31M

Operating Cash Flow

$131.56M

Capital Expenditure

$0.00

Free Cash Flow

$131.56M

Cash & ST Invst.

$411.59M

Total Debt

$0.00

Definium Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$2.37B

N/A

Market Cap/Employee

$31.98M

N/A

Employees

74

N/A

Net Income

$50.44M

-45.2%

EBITDA

$40.75M

-19.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$411.59M

+63.4%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

N/A

Return on Assets

-41.76%

N/A

Return on Invested Capital

-44.54%

N/A

Free Cash Flow

$41.89M

-65.2%

Operating Cash Flow

$41.89M

-65.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KODKodiak Sciences Inc.
$43.89-0.16%
TNGXTango Therapeutics, Inc.
$23.03+9.77%
ANABAnaptysBio, Inc.
$69.66+4.34%
NRIXNurix Therapeutics, Inc.
$16.91+0.58%

Trending Stocks

Symbol / CompanyPricePrice Chg
CNSPCns Pharmaceuticals
$7.71+2.34%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.12+0.00%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.74+0.01%
XNDUXanadu Quantum Technologies
$14.68-0.59%

Questions About DFTX

What is the current price of Definium Therapeutics?

Definium Therapeutics is trading at $21.79 per share.

What is the 52-week range for Definium Therapeutics?

Over the past 52 weeks, Definium Therapeutics has traded between $6.03 and $26.25.

How much debt does Definium Therapeutics have?

As of the most recent reporting period, Definium Therapeutics reported total debt of $40.58M.

How much cash does Definium Therapeutics have on hand?

Definium Therapeutics reported $257.84M in cash and cash equivalents in its most recent financial results.

What is Definium Therapeutics’s dividend yield?

Definium Therapeutics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services